High expression levels of CXCL12 in the tumor stroma have been detected in various human cancers, including gastric, bladder, and ovarian cancer through immunohistochemistry (IHC), and CXCL12 upregulation correlated with poor prognosis5–7. Here, CXCL12 is linked to ovarian carcinoma.